MORE than 13,000 doses of Covid-19 vaccines have been administered by the Subic Bay Metropolitan Authority (SBMA) for workers and residents in the Subic Bay Freeport under the agency’s vaccination program in partnership with the Department of Health (DOH).

SBMA Chairman and Administrator Wilma T. Eisma said the vaccine rollout seeks to ensure adequate protection for stakeholders in Subic and facilitate the revival of local businesses affected by the Covid-19 pandemic

“We’re gunning for herd immunity with the vaccination program in Subic because that’s the only way that we can reopen and sustain the economy. We need to vaccinate at least 70 percent of the residents and workers in the Freeport so that we can minimize, if not contain, the spread of the virus,” Eisma said.

She said that as far as SBMA employees are concerned, 82 percent of the agency’s 2,249 workforce are already fully vaccinated while 12 percent are awaiting their second dose.

“On the other hand, we still have a long way to go among residents and workers in the Freeport, but with more vaccine allocation from the DOH, we are closing the gap steadily,” she added.

“It also helped a lot that we have received donations of biomedical refrigerators, as well as freezers and vaccine transporters, thus enhancing our capacity for storage and distribution,” Eisma said.

According to Dr. Solomon Jacalne, head of the SBMA Public Health and Safety Department (PHSD), the agency’s health workers have already administered a total of 13,063 vaccine doses as of November 24. This is broken down into 8,404 first doses and 4,659 second doses.

Most of the beneficiaries of the SBMA-DOH vaccine rollout are residents of Olongapo City, who received a total of 8,138 doses.

Meanwhile, 1,937 jabs have been administered to residents of the Subic Bay Freeport Zone; 1,653 doses for residents of Zambales; and 1,335 shots for those coming from communities outside Zambales.

Figures from the SBMA-PHSD also showed that most of the shots administered were Pfizer vaccines with a total of 5,516 doses, followed by Sinovac, with 3,881 shots; Astra Zeneca, with 3,306; and Janssen, with 360.